共 17 条
[1]
On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer,TATA box, and RNA start site (Inr motif) occlusion. Ray A,LaForge KS,Sehgal PB. Molecular and Cellular Biology . 1990
[2]
The biological properties of interleukin-1. Dinarello CA. European Cytokine Network . 1994
[3]
17 beta-estradiol inhibits expression of human interleukin-6 promoter-reptorer constructs by a receptor-dependent mechanism. Pottratz ST,Bellido T,Mocharla H,et al. The Journal of Clinical Investigation . 1994
[4]
Direct modulation of os-teoblastic activity with estrogen. Majeska RJ,Ryaby JT,Einhorn TA. Journal of Bone and Joint Surgery British Volume . 1994
[5]
Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorption osteoclasts. Kameda T,Mano H,Yuasa T,et al. The Journal of Experimental Medicine . 1997
[6]
Skeletal effects of estrogen. Turner RT,Riggs BL,Spelsberg TC. Endocrine Reviews . 1994
[7]
Estrogen inhibits interleukin-6production and gene expressionin a human osteoblastic cell line with high levels of estro-gen receptors. Kassem M,Harris S A,Spelsberg T Cet al. Journal of Bone and Mineral Research . 1996
[8]
Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. Kania DM,Binkley N,Checovich M,et al. Journal of the American Geriatrics Society . 1995
[9]
Modulation of transforming growth factors-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Oursler MJ,Cortese C,Keeting P,et al. The Journal of Endocrinology . 1991
[10]
17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. Girasole G,Jilka RL,Passeri G,et al. The Journal of Clinical Investigation . 1992